NASDAQ:BSEM

Biostem Technologies (BSEM) Stock Price, News & Analysis

Biostem Technologies logo
$0.82 +0.01 (+0.83%)
As of 03:02 PM Eastern
This is a fair market value price provided by Massive. Learn more.

About Biostem Technologies Stock (NASDAQ:BSEM)

Advanced

Key Stats

Today's Range
$0.83
▼
$0.94
50-Day Range
$0.82
▼
$4.74
52-Week Range
$0.81
▼
$8.40
Volume
222,740 shs
Average Volume
114,986 shs
Market Capitalization
$15.82 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.00
Consensus Rating
Hold

Company Overview

BioStem Technologies is a biotechnology company focused on developing and commercializing human placental tissue allografts for regenerative medicine. Its products are made from donated birth tissue and are intended for use by healthcare professionals in areas including wound care and surgical applications.

The company’s portfolio includes products marketed under brands such as VENDAJE, Neox and Clarix. BioStem uses its BioRetain processing method to prepare placental tissue while retaining key characteristics of the original material.

BioStem serves healthcare providers in the United States. Its business centers on supplying these tissue-based products for clinical use; the company’s product offerings and applications are subject to applicable regulatory requirements.

AI Generated. May Contain Errors.

Biostem Technologies Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
72nd Percentile Overall Score

BSEM MarketRank™: 
3.575323790045 of 5 stars

Biostem Technologies scored higher than 72% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Biostem Technologies has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 strong buy rating, no buy ratings, 1 hold rating, and 1 sell rating.

  • Upside Potential

    Biostem Technologies has a consensus price target of $9.00, representing about 918.1% upside from its current price of $0.88.

  • Amount of Analyst Coverage

    Biostem Technologies has only been the subject of 1 research reports in the past 90 days.

  • Read more about Biostem Technologies' stock forecast and price target.
  • Earnings Growth

    Earnings for Biostem Technologies are expected to grow in the coming year, from ($1.90) to ($1.04) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Biostem Technologies is -0.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Biostem Technologies has a P/B Ratio of 0.92. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    1.54% of the float of Biostem Technologies has been sold short.
  • Short Interest Ratio / Days to Cover

    Biostem Technologies has a short interest ratio ("days to cover") of 1.53, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Biostem Technologies has recently decreased by 14.05%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Biostem Technologies does not currently pay a dividend.

  • Dividend Growth

    Biostem Technologies does not have a long track record of dividend growth.

  • News Sentiment

    Biostem Technologies has a news sentiment score of -0.51. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.63 average news sentiment score of companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for Biostem Technologies this week, compared to 2 articles on an average week.
  • Search Interest

    Only 26 people have searched for BSEM on MarketBeat in the last 30 days. This is a decrease of -13% compared to the previous 30 days.
  • MarketBeat Follows

    2 people have added Biostem Technologies to their MarketBeat watchlist in the last 30 days.
Receive BSEM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biostem Technologies and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BSEM Stock News Headlines

BioStem (BSEM) Q3 2026 Earnings Call Transcript
Why I'm selling my Snapback Indicator for just $7
For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indicator for a single $7 payment. Others previously paid $500. The indicator flashes a Crash Alert as a cue to exit or go short, and a Bull Run Alert as a cue to buy or go long. No strings attached, and Wood says there is an unusual reason behind the steep discount.tc pixel
BioStem Technologies (BSEM) AI Stock Analysis
See More Headlines

BSEM Stock Analysis - Frequently Asked Questions

Biostem Technologies' stock was trading at $3.9090 on January 1st, 2026. Since then, BSEM shares have decreased by 77.4% and is now trading at $0.8840.

Biostem Technologies, Inc. (NASDAQ:BSEM) posted its quarterly earnings results on Thursday, November, 12th. The company reported ($0.64) earnings per share for the quarter, missing the consensus estimate of ($0.43) by $0.21. The firm had revenue of $7.64 million for the quarter, compared to analysts' expectations of $7.17 million. Biostem Technologies had a negative trailing twelve-month return on equity of 116.63% and a negative net margin of 121.02%.
Read the conference call transcript
.

Shares of BSEM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Biostem Technologies investors own include NVIDIA (NVDA), Super Micro Computer (SMCI), Palantir Technologies (PLTR), Advanced Micro Devices (AMD), Tesla (TSLA), Broadcom (AVGO) and SoundHound AI (SOUN).

Company Calendar

Last Earnings
11/12/2026
Today
11/19/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:BSEM
Previous Symbol
OTCMKTS:BSEM
CIK
1658678
Web
N/A
Fax
N/A
Employees
2
Year Founded
N/A

Price Target and Rating

High Price Target
$9.00
Low Price Target
$9.00
Potential Upside/Downside
+996.2%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.27)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$6.58 million
Net Margins
-121.02%
Pretax Margin
N/A
Return on Equity
-116.63%
Return on Assets
-57.99%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.73
Quick Ratio
0.44

Sales & Book Value

Annual Sales
$47.48 million
Price / Sales
0.33
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.96 per share
Price / Book
0.86

Miscellaneous

Outstanding Shares
19,180,000
Free Float
N/A
Market Cap
$15.75 million
Optionable
N/A
Beta
0.36
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

This page (NASDAQ:BSEM) was last updated on 11/19/2026 by MarketBeat.com Staff.
From Our Partners